Skip to main content
Syncom Formulations (India) Ltd. logo

Syncom Formulations (India) Ltd. — Investor Relations & Filings

Ticker · SYNCOMF ISIN · INE312C01025 LEI · 335800QILNIFQEETDU74 BSE.NS Manufacturing
Open in API
Filings indexed 196 across all filing types
Latest filing 2026-05-23 Regulatory Filings
Country IN India
Listing BSE.NS SYNCOMF

About Syncom Formulations (India) Ltd.

https://syncomformulations.com/

Syncom Formulations (India) Ltd. is a pharmaceutical organization specializing in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company maintains an extensive portfolio of over 400 products across various therapeutic categories, including analgesics, antibiotics, anti-infectives, and nutritional supplements. Its manufacturing capabilities encompass multiple dosage forms such as tablets, capsules, liquid orals, dry syrups, and topical preparations. Operating from a WHO-GMP certified facility, the company serves both domestic and international markets, exporting products to numerous countries across the globe. In addition to its proprietary brands, the company provides contract manufacturing services to global pharmaceutical entities, leveraging its technical expertise and quality-driven production processes to meet international standards.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 92% confidence The document is a letter from Syncom Formulations (India) Limited to the BSE and NSE submitting the newspaper advertisement (“press clipping”) of the extract of audited quarter/year-ended financial results pursuant to SEBI LODR Regulations. It does not itself contain detailed financial statements or management commentary, nor is it the full annual or interim report—it is a compliance/regulatory disclosure. Under the classification scheme, this falls under general regulatory announcements (RNS).
2026-05-23 English
Submission of Press Clipping related to extract of Audited Financial Results for the year ended 31.03.2026
Report Publication Announcement Classification · 90% confidence The document is a short exchange filing under SEBI LODR Regulations to stock exchanges, enclosing a newspaper advertisement (press clipping) of an extract of the audited quarter/year-ended financial results and directing that the full results are available via QR code/website. It does not contain the actual financial data itself but is an announcement that the extract has been published. Under the “Menu vs Meal” rule, this is a report publication announcement rather than the report content, fitting code RPA.
2026-05-23 English
Pursuant to regulation 33(3)(d) of SEBI LODR Regulations, 2015 we are pleased to submit the financials for the year ended on 31st March, 2026
Interim / Quarterly Report Classification · 75% confidence The document is a detailed submission under SEBI LODR Regulation 33 containing the standalone and consolidated audited financial results (profit & loss, segment results, assets & liabilities, cash flows) for the quarter and full year ended 31 March 2026, along with the auditors’ report. It is not merely an announcement or summary of results (ER/RPA), nor a full multi‐section annual report (10-K) with MD&A, nor a proxy or governance filing. It contains substantive audited financial statements similar to a quarter/half‐year report and does not fit the pure audit report or management discussion categories. This aligns with an Interim/Quarterly Report (IR) type filing. FY 2026
2026-05-22 English
Outcome of Board Meeting
Audit Report / Information Classification · 80% confidence The document is a SEBI LODR Reg. 33 submission containing the Statutory Auditors’ Report along with the full standalone audited financial results, statement of assets & liabilities, cash flows, segment disclosures, and an unmodified audit opinion for the year ended 31 March 2026. It is not a full annual management report (10-K/Annual Report), nor merely an announcement, nor just highlights. This matches the definition of an Audit Report/Information filing (AR). FY 2026
2026-05-22 English
Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Standalone & Consolidated Audited Financial Results along with Auditors' Report thereon by ....
Interim / Quarterly Report Classification · 73% confidence The document is a regulatory filing under SEBI LODR Regulation 33(3)(d) containing the full audited standalone and consolidated financial results, including profit & loss, assets & liabilities, cash flows and segment disclosures for the quarter and year ended 31 March 2026. It goes beyond a simple press‐release (earnings highlights) and includes substantive financial statements. Although it covers the full fiscal year, it also reports the quarter‐end figures in detail, fitting the definition of a comprehensive interim/quarterly report with actual financial data rather than merely announcing or certifying results. Therefore it is best classified as an Interim / Quarterly Report (IR). FY 2026
2026-05-22 English
In terms of REG 24A of Listing Regulations, as amended read with master circular we hereby submit the Annual Secretarial Compliance Report for the year ended 31st March, 2026
Regulatory Filings Classification · 82% confidence The document is the Annual Secretarial Compliance Report submitted under SEBI Listing Regulations by the Company Secretary, containing detailed compliance certifications and observations under Regulation 24A for the year ended 31 March 2026. It is not a financial statement (10-K, IR, ER, etc.) nor a presentation or proxy solicitation; rather it is a regulatory compliance filing and officer certification. This type of compliance report falls under the general “Regulatory Filings” category.
2026-05-18 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.